Filing Details
- Accession Number:
- 0001209191-21-041496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-17 17:01:10
- Reporting Period:
- 2021-06-15
- Accepted Time:
- 2021-06-17 17:01:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1802653 | Ray Stephen Mitchell | C/O Vanda Pharmaceuticals Inc. 2200 Pennsylvania Avenue, Suite 300E Washington DC 20037 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-15 | 4,015 | $10.57 | 14,215 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-15 | 5,000 | $19.42 | 9,215 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-15 | 4,015 | $0.00 | 4,015 | $10.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,985 | 2030-06-10 | No | 4 | M | Direct |
Footnotes
- A portion of the shares was sold to satisfy the exercise price of the stock option and the tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021.
Billionaire Hedge Funds
